Reply to comment
I am a CML patient and have been on 600mg Gleevec since 12/2002. In the past 5+ years, my insurance company has paid Novartis over $300,000. Novartis has also instituted 2 price INCREASES, hardly a 'patient friendly' action. So, while every company has a right to make a profit, this is without a doubt price gouging. I agree that govt price controls would eliminate the profit motive for developing new, innovative designer drugs like Gleevec. That doesn't excuse the pharmas from their heartless profiteering. Thank God for my health benefits. God help me if I ever lose them.
Ralph